Ariz. Admin. Code § R9-6-317 - Carbapenem-resistant Acinetobacter baumannii
A. Case control measures:
1. A diagnosing health care provider or an
administrator of a health care institution, either personally or through a
representative, shall:
a. Institute isolation
precautions as necessary for a case with carbapenem-resistant
Acinetobacter baumannii infection or colonization to prevent
transmission; and
b. If a case with
carbapenem-resistant Acinetobacter baumannii infection or
colonization is being transferred to another health care provider or health
care institution or to a correctional facility, comply with
R9-6-305.
2. An administrator of a correctional
facility, either personally or through a representative, shall:
a. Institute isolation precautions as
necessary for a case with carbapenem-resistant Acinetobacter
baumannii infection or colonization to prevent transmission;
and
b. If a case with
carbapenem-resistant Acinetobacter baumannii infection or
colonization is being transferred to another correctional facility or to a
health care institution, comply with R9-6-305.
3. A local health agency, in consultation
with the Department, shall ensure that
a. A
case with carbapenem-resistant Acinetobacter baumannii
infection or colonization is isolated as necessary to prevent transmission;
and
b. An isolate or a specimen, as
available, from each case with carbapenem-resistant Acinetobacter
baumannii infection or colonization is submitted to the Arizona State
Laboratory.
B.
Outbreak control measures: A local health agency shall:
1. Conduct an epidemiologic investigation for
each outbreak or suspected outbreak of carbapenem-resistant
Acinetobacter baumannii; and
2. For each outbreak or suspected outbreak of
carbapenem-resistant Acinetobacter baumannii, submit to the
Department the information required under R9-6-206(E).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
A. Case control measures: A local health agency shall:
1. Conduct an epidemiologic investigation of each reported chancroid case or suspect case;
2. For each chancroid case, submit to the Department, as specified in Table 2.4, the information required under R9-6-206(D); and
3. Comply with the requirements specified in R9-6-1103 concerning treatment and health education for a chancroid case.
B. Contact control measures: When a chancroid case has named a contact, a local health agency shall comply with the requirements specified in R9-6-1103 concerning notification, testing, treatment, and health education for the contact.